Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $289,580 | 138 | 67.2% |
| Travel and Lodging | $70,458 | 180 | 16.4% |
| Food and Beverage | $37,966 | 1,535 | 8.8% |
| Consulting Fee | $31,170 | 10 | 7.2% |
| Honoraria | $1,500 | 1 | 0.3% |
| Education | $233.15 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $251,757 | 619 | $0 (2024) |
| ViiV Healthcare Company | $102,783 | 332 | $0 (2024) |
| EMD Serono, Inc. | $38,099 | 241 | $0 (2024) |
| Janssen Products, LP | $21,281 | 27 | $0 (2023) |
| Theratechnologies Inc. | $4,702 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $1,948 | 106 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,904 | 118 | $0 (2024) |
| ABBVIE INC. | $1,368 | 65 | $0 (2024) |
| Novo Nordisk Inc | $1,327 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,187 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,959 | 235 | Gilead Sciences, Inc. ($38,431) |
| 2023 | $37,090 | 194 | ViiV Healthcare Company ($29,316) |
| 2022 | $36,054 | 167 | Gilead Sciences, Inc. ($21,456) |
| 2021 | $21,852 | 186 | Gilead Sciences, Inc. ($13,605) |
| 2020 | $37,360 | 180 | Gilead Sciences, Inc. ($24,531) |
| 2019 | $110,046 | 329 | Gilead Sciences, Inc. ($82,361) |
| 2018 | $68,492 | 310 | Gilead Sciences, Inc. ($43,734) |
| 2017 | $45,054 | 270 | Gilead Sciences Inc ($26,934) |
All Payment Transactions
1,871 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: HIV | ||||||
| 12/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| 12/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: HIV | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.89 | General |
| 12/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.43 | General |
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: HIV | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.35 | General |
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.25 | General |
| 12/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.22 | General |
| 12/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.34 | General |
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.22 | General |
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: HIV | ||||||
| 11/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.71 | General |
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.15 | General |
| 11/14/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Diagnostics | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.18 | General |
| 11/12/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Infectious Disease | ||||||
| 11/07/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,542 | 6,899 | $906,272 | $367,007 |
| 2022 | 22 | 1,723 | 6,434 | $842,383 | $363,118 |
| 2021 | 20 | 1,148 | 3,085 | $484,845 | $229,546 |
| 2020 | 24 | 1,415 | 3,130 | $436,917 | $203,337 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 131 | 940 | $186,220 | $80,780 | 43.4% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 102 | 1,501 | $142,955 | $68,235 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 521 | $107,256 | $56,307 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 350 | $55,884 | $26,280 | 47.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 105 | 916 | $137,400 | $24,472 | 17.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 114 | 433 | $35,610 | $22,395 | 62.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 93 | 730 | $85,860 | $19,724 | 23.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 69 | 310 | $38,625 | $16,368 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $21,600 | $11,265 | 52.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 282 | $16,920 | $8,904 | 52.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 71 | 228 | $22,800 | $6,777 | 29.7% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 78 | 248 | $17,360 | $6,331 | 36.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 57 | 59 | $8,270 | $3,974 | 48.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 42 | 43 | $3,275 | $3,154 | 96.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 16 | $5,200 | $2,526 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 58 | $4,350 | $2,154 | 49.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 35 | $3,500 | $1,548 | 44.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,760 | $1,439 | 81.8% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 41 | $2,665 | $1,285 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,720 | $1,207 | 32.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $481.50 | $407.69 | 84.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,795 | $393.39 | 21.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 27 | $1,066 | $366.34 | 34.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $420.00 | $283.08 | 67.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $369.05 | $259.49 | 70.3% |
About Dr. Anthony Jones, MD
Dr. Anthony Jones, MD is a Family Medicine healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538246194.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Jones, MD has received a total of $430,907 in payments from pharmaceutical and medical device companies, with $74,959 received in 2024. These payments were reported across 1,871 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($289,580).
As a Medicare-enrolled provider, Jones has provided services to 5,828 Medicare beneficiaries, totaling 19,548 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oakland, CA
- Active Since 11/01/2006
- Last Updated 07/23/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538246194
Products in Payments
- Biktarvy (Drug) $86,747
- DOVATO (Drug) $78,392
- SEROSTIM (Biological) $36,101
- Descovy (Drug) $34,626
- Truvada (Drug) $20,703
- SYMTUZA (Drug) $17,974
- Genvoya (Drug) $7,887
- CABENUVA (Biological) $5,670
- TIVICAY (Drug) $4,567
- Symtuza (Drug) $4,143
- EGRIFTA (Drug) $3,073
- PREZCOBIX (Drug) $1,183
- ISENTRESS (Drug) $1,115
- TRIUMEQ (Drug) $771.86
- RUKOBIA (Drug) $717.96
- APRETUDE (Biological) $582.18
- JULUCA (Drug) $571.73
- PIFELTRO (Drug) $487.77
- Mytesi (Drug) $484.44
- Ozempic (Drug) $371.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oakland
Dr. Sandra Win, M.d, M.D
Family Medicine — Payments: $12,757
Dr. Barton Thrasher, Md, MD
Family Medicine — Payments: $6,973
Knar Mesrobian, Do, DO
Family Medicine — Payments: $6,429
Richard Morski, Md, MD
Family Medicine — Payments: $5,490
Shiu-Lan Lui, M.d, M.D
Family Medicine — Payments: $4,490
Louis Perdomo, Md, MD
Family Medicine — Payments: $3,761